TAM
FBRX icon

Tocqueville Asset Management’s Forte Biosciences FBRX Stock Holding History

Tocqueville Asset Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-580
Closed -$487K – 733
2021
Q2 		$487K Buy
580
+80
+16% +$72.1K 0.01% 558
2021
Q1 		$428K Buy
500
+186
+59% +$152K 0.01% 578
2020
Q4 		$286K Sell
314
-6
-2% -$5.64K ﹤0.01% 628
2020
Q3 		$388K Sell
320
-88
-22% -$58.3K 0.01% 537
2020
Q2 		$149K Buy
+408
New +$182K ﹤0.01% 636

Other funds holding FBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.88B AUM 35.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Tocqueville Asset Management's FBRX Position: Q3 2021 in Review

Tocqueville Asset Management sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 580 shares — an estimated $487K sold.

Tocqueville Asset Management first reported a position in FBRX in Q2 2020 and held it in 5 quarters. The position peaked at $487K in Q2 2021. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • Tocqueville Asset Management reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • Tocqueville Asset Management sold 580 Forte Biosciences shares in Q3 2021, an estimated $487K.
  • Tocqueville Asset Management first reported a position in Forte Biosciences in Q2 2020 and held it in 5 quarters.
  • Tocqueville Asset Management's Forte Biosciences position peaked at $487K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on Tocqueville Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.